Introduction
Hatay Pharmaceutical Joint Stock Company (Hataphar) is a Vietnam-based pharmaceutical company. It is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The Company also manufactures and trades cosmetic products, supplemental food, general chemicals and specialized chemicals for laboratory tests. Other activities include supermarket operations, office and apartment leasing, real estate brokerage services, as well as the provision of vocational training services. The Company announced that it has completed the acquisition of 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company by the end of the third quarter of 2013.
Business sector
History
Date of incorporation | 01/01/0001 |
Certificate of registration number | 0500391400 |
Date of issue | 15/01/2024 |
Capital | 823,417,730,000 |
Tax Code | 0500391400 |
Sectors & Industries | Health Care > Pharmaceuticals |
Listing information
Date of listing | 15/01/2024 |
Stock exchange | HASTC |
Par Value | 10,000 |
Initial Listing Price | 25,000 |
Listing Volume | 73,941,773 |
Total Listing Value | 739,417,730,000 |
Management team
Lê Văn Lớ | Chairman of the Board of Directors |
Lê Anh Trung | Vice-chairman of the Board |
Keisuke Oshio | Members of the Board |
Lê Xuân Thắng | Members of the Board |
Hiroyasu Nishioka | Members of the Board |
Lê Việt Linh | Members of the Board |
Hoàng Văn Tuế | Members of the Board |
Ngô Văn Chinh | Board of internal controllers |
Nguyễn Hà Đệ | Member of the Board of Internal controllers |
Lê Xuân Thắng | Chief of Executive Officer |
Ngô Tuấn Việt | Deputy CEO |
Lê Việt Linh | Deputy CEO |
Nguyễn Bá Lai | Deputy CEO |
Lê Anh Trung | Deputy CEO |
Hoàng Văn Tuế | Chief Accountant |
Ngô Văn Chinh | Representative Spokesman |